Place two packs of CBD seeds beside each other, one labelled 1:1 and the other 20:1, and the two look the same: the same brand foil, the same seed count, contents that no eye can tell apart. Grow them side by side and they go their separate ways at the first stage and do not meet again. The cause is one single gene, and the easiest way to understand what it does is to track the two packs through every stage they go through: the breeding that produced them, the seed, the seedling, the flower tent, the harvest, the jar, the lab bench and the border. The lines quoted as reference points below are drawn from the range at https://calmcbdseeds.com, which goes 1:1, 2:1 and 20:1 and a top line at around 30 to one; the genetics holds the same whichever shop the seeds came from.
Before the Seed Exists
Cannabis decides whether it will make THC or CBD at one position on the genome. The gene there comes in two forms: one builds the enzyme that converts the common starting molecule into THCA, the other the enzyme that turns it into CBDA. Each plant holds two copies, one inherited from either parent, and the pair sets the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies make a CBD-dominant one. One of each makes a balanced plant, since the two forms are codominant and neither silences the other.
The balanced pack was bred by pairing two balanced plants, both holding one copy of each form. The CBD-dominant pack was made by pairing two plants that both carry two CBD copies and not a single THC copy between them. This one fact at the bench decides all that follows afterwards, and the difference is already in the seed long before it is packed.
The Mendelian Split
Cross two balanced plants and the seeds sort themselves by the oldest arithmetic in genetics: a quarter inherit two THC copies, a quarter get two CBD copies, half get one of each. In a pack of 10 seeds that means, on average, two or three THC-dominant seeds, two or three CBD-dominant ones, and about five genuine balanced ones. The pack is sold by its parents, and for half its contents the label is accurate; in the case of the other half it is a description of something else. Calm CBD Seeds states the expected split on each balanced line, which means the buyer knows before planting that a portion of the plants will depart from the stated ratio.
The CBD-dominant pack has no such split. Every seed received a CBD copy from both parents, every plant is going to be CBD-dominant, and the ratio on the foil holds to all of them, within the ordinary differences in the amount of total cannabinoid any individual plant produces. Breeders describe these lines “breed true” for chemotype; the phrase refers to precisely this absence of surprise.
Stage Three: The Seedling Tray
Here the two packs appear alike again, and the likeness lasts longer than most growers assume. Chemotype leaves no trace on a seedling. Leaf shape, colour, internode length and the speed of growth rate are governed by different genes altogether, and the three chemotypes of plant in the balanced pack come up indistinguishably from one another and from each plant in the CBD-dominant pack.
One real distinction at this stage comes from lineage rather than chemotype. Strains with strong hemp ancestry, and that includes some less developed CBD-dominant strains, are inclined to stretch taller and branch more sparsely. A well-worked 20:1 strain behaves like a normal modern hybrid; a early-generation one still carry the field in its frame. Not one of these tendency tells anything about the ratio to come.
When the Resin Comes In
In flower the two packs start to offer clues, and the majority of them mislead. Resin coverage is the first thing a grower judges, and it was a reasonable guide: first-generation CBD-dominant strains carried markedly less frost than their THC cousins, an unwanted legacy from hemp. Current selections have largely erased that gap, and a less frosted plant from the CBD-dominant pack may still come in precisely where the foil said. Trichome density and chemotype are inherited separately.
Smell is an even poorer guide. The terpene chemistry sits on yet other genes, so the THC-dominant plant hiding in the balanced pack can be indistinguishable to the balanced one next to it, and either can be indistinguishable to a plant from the CBD-dominant pack. People who try to separate a balanced pack by nose in week eight are right about half the time, which is no any better than leaving the plants unsorted at all.
One Place CBD Is More Forgiving
At this stage the two packs diverge in a way that benefits the grower of the CBD-dominant pack and also the CBD-dominant plants hidden in the balanced pack. CBDA breaks down rather gradually than THCA, so a CBD-dominant plant left a week past its ideal point keeps the bulk of its cannabinoid load, where a THC-dominant one in the same conditions has by then started converting THC to CBN. The usual trichome rules still applies; it holds on account of the terpenes, which fade on any plant regardless the chemotype, and a late, rushed CBD flower smells of little whatever the test result says.
Stage Six: The Jar
The CBD-dominant pack can go into one jar. Every plant from it holds roughly the same ratio, and mixing them changes nothing worth measuring. The balanced pack cannot be handled that way. Pool its 10 plants in a single jar and the result become a ratio that no foil ever predicted, skewed by whichever plants grew most, and nothing on a subsequent test can untangle the plants that went in.
The habit that saves the grief is dull: cut the balanced pack plant by plant, dry every one separately, number each, and try them plant at a time before anything is mixed. It is the only stage in the whole grow where the different kinds of plant in the balanced pack can yet be kept apart short of a lab, and then only for the reason that every one is still in its own bag.
Reading the Two Results
Submit a few grams from every jar to a laboratory and the two packs at last are legible. For the CBD-dominant pack the reports come back grouped closely around the stated ratio, varying mainly in total cannabinoid content not in proportion. For the balanced pack they arrive back in three groups: some plants with almost all THC, a few showing nearly all CBD, and the rest sitting near one to one. No part of this pattern is a defect; it is the breeder’s cross written out as numbers.
Over-the-counter test kits are sold for growers who cannot reach a lab, and the majority of them show whether THC is present rather than how much. That is enough to separate the THC-dominant plants away from a balanced pack and insufficient enough to put a ratio to the others, and that matches the commonest need: knowing which of the 10 jars is going to surprise someone.
Stage Eight: The Border
The last stage at which the two packs diverge is in law, and it catches growers who thought “CBD” was shorthand for “hemp”. Most countries define hemp by a THC ceiling, a small fraction of a percent of dry weight, with the precise figure differing by country and year to year. A plant from the CBD-dominant pack producing twenty percent CBD at twenty to one at the same time makes about one percent THC, and that is several times above most thresholds. Compliant cultivars are selected to keep total cannabinoid output down so the THC fraction remains below the line right up to maturity; CBD flower lines are bred for rich content and let the THC scale with it. A seller that offers only a ratio is selling a flower line; anyone who needs a legal hemp crop should ask for a tested THC figure at maturity and buy nothing that cannot provide one.
Past the threshold issue, the chemotype changes nothing about the law on the seed itself. In places where holding cannabis seeds is permitted and germinating them is not, the balanced pack and the CBD-dominant pack sit under the same position as any other pack. Where the plant is permitted without restriction, the decision between them is a matter of preference and nothing else’s. None of this page is legal advice, and the rule which applies is the one where the seed is going to be grown, not the one where it was bought.